Vera Therapeutics, Inc. (VERA) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$299.62M | -96.9% |
| 2024 | -$152.15M | -58.5% |
| 2023 | -$95.99M | -7.8% |
| 2022 | -$89.06M | -173.1% |
| 2021 | -$32.61M | +38.9% |
| 2020 | -$53.41M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$299.62M | -96.9% |
| 2024 | -$152.15M | -58.5% |
| 2023 | -$95.99M | -7.8% |
| 2022 | -$89.06M | -173.1% |
| 2021 | -$32.61M | +38.9% |
| 2020 | -$53.41M | — |